XOMA Xoma Corp

XOMA Corp is a biotechnology company. It discovers and develops human and humanized monoclonal antibody-based therapeutics.

As of 10/05/2022     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  11/19/2012
Outstanding shares:  11,450,823
Average volume:  44,787
Market cap:   $194,778,499
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BYP7GF0
Valuation   (See tab for details)
PE ratio:   16.44
PB ratio:   1.41
PS ratio:   4.76
Return on equity:   14.93%
Net income %:   51.09%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy